NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Cyber Incident Reporting Regulation Takes Shape
An upcoming CISA rule aims to harmonize cyber incident reporting requirements for critical infrastructure entities.
5m read -
Connectivity Drives Future of Defense
The Defense Department is strategizing new operating concepts ahead of future joint force operations.
8m read -
5 Predictions for AI in Government Technology
Agencies are setting plans in motion not only to integrate AI into their enterprises, but also ensuring the data that power these systems are fair.
41m watch -
Agencies Meet Key AI Goals Amid Call for More Experimentation
Federal leaders call for prioritizing artificial intelligence and its applications to critical cybersecurity and workforce initiatives.
7m read